by Ashley | Jul 22, 2020 | COVID-19, Press Release
Personalized Stem Cells, Inc. (PSC) has received FDA approval for an Investigational New Drug (IND) application for the treatment of COVID-19 patients with stem cells. The first trial is named “CoronaStem 1” and will provide treatment for 20 hospitalized COVID-19...
by Ashley | May 20, 2020 | Press Release
The COVID-19 pandemic has taken our world by storm. Millions of people have contracted the virus with over 300,000 confirmed deaths. While self-isolation occurs across the globe, scientists and medical professionals are rushing to find safe and effective treatments to...
by Ashley | May 1, 2020 | Blog, COVID-19
On April 27, 2020 PSC CEO, Dr. Bob Harman and PSC Medical Director, Dr. Christopher Rogers, were interviewed by San Diego CBS affiliate, KFMB TV. The interview provides an excellent overview of how Personalized Stem Cells is working with the FDA and the White House...
